Skip to main content
BEAT
NASDAQ Industrial Applications And Services

Director Mark Strome Invests $600K in HeartBeam Public Offering Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.849
Mkt Cap
$33.281M
52W Low
$0.54
52W High
$4
52W Position info
57% above low
Off High info
79% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

BEAT sits 57% above its 52-week low of $0.54.

Summary

HeartBeam Director Mark E. Strome purchased $600,000 worth of common stock as part of the company's recently closed public offering, signaling strong confidence despite prior 'going concern' warnings.


Key Events · Ownership and Investor Activity · BEAT

  • Director Participates in Public Offering

    Director Mark E. Strome purchased 750,000 shares of HeartBeam common stock for $600,000 at a price of $0.80 per share.

  • Significant Insider Investment

    The $600,000 purchase represents a substantial investment by a director, equivalent to over 1.8% of the company's market capitalization.

  • Vote of Confidence Amidst Financial Concerns

    This investment comes shortly after the company's auditors expressed 'substantial doubt about its ability to continue as a going concern,' indicating strong insider conviction in the company's outlook.

  • Follows Recent Capital Raise

    The purchase was made in connection with the public offering that priced on April 14, 2026, and closed on April 16, 2026, providing crucial capital for HeartBeam's operations.


Analysis · BEAT · Industrial Applications And Services

This Form 4 filing reveals a significant investment by Director Mark E. Strome, who acquired $600,000 in HeartBeam common stock through the company's recently completed public offering. This purchase, representing over 1.8% of the company's market capitalization, is particularly notable given the company's previously disclosed 'substantial doubt about its ability to continue as a going concern.' An insider's direct participation in a dilutive capital raise, especially from a director, provides a strong vote of confidence in the company's future and its ability to navigate its financial challenges. This investment aligns with the recent closing of the public offering, which secured crucial capital for operations.

At the time of this filing, BEAT was trading at $0.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.3M. The 52-week trading range was $0.54 to $4.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Jul 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.720
Real-time Price: $0.5318 info
Change: -$0.1882 (-26%) info
Market Cap: $29.136M info
BEAT
Jun 24, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.698
Real-time Price: $0.5318 info
Change: -$0.1662 (-24%) info
Market Cap: $29.136M info
BEAT
Jun 24, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.692601
Real-time Price: $0.5318 info
Change: -$0.160801 (-23%) info
Market Cap: $29.136M info
BEAT
Jun 22, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7199
Real-time Price: $0.5318 info
Change: -$0.1881 (-26%) info
Market Cap: $29.136M info
BEAT
Jun 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7101
Real-time Price: $0.5318 info
Change: -$0.1783 (-25%) info
Market Cap: $29.136M info